Exchange: NASDAQ·Updated 07:30 PM EDT
NBTX logo

NBTX Nanobiotix - ADR

$33.05
$2.83
(7.89%)
Today
Closed $33.05
$0.00
(0.00%)
After Hours
EarningsSep 29
Mkt Cap$1.67B
Vol149,344.00

About NBTX

Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells. The company was founded by Laurent Lévy and Abdel Kader Boussaha on March 4, 2003 and is headquartered in Paris, France.
49

Neutral Sentiment

How do you feel about NBTX?

focafoca99
$NBTX revealed full Phase 1 cohort results showing 79% 1-yr locoregional control and 70% overall survival in recurrent NSCLC.

Advertisement|Remove ads.